SRF · risk themes across the available quarters.
Bear-case history
Some demand deferment observed in agrochemical spectrum space with new product traction partially offsetting. Management does not believe demand is lost but delayed. Specialty chemicals H2 strength is expected but global headwinds persist.
Aggressive import pricing of NTCF and belting fabrics from China creating margin headwinds. Belting fabric and NTC volumes grew YoY but realizations remain under pressure. Monsoon impacted domestic demand for certain products.
Packaging film exports to US impacted by tariffs; mitigation underway by routing through Thailand facility. HFC pricing also faces some impact from tariffs while still remaining solid. Specialty chemicals US exports ~Rs 300 crore (not material at overall level).
Rahul Jain (President and CFO) announced at Q2 FY26 earnings call that he will step down on December 12, 2025 to pursue other opportunities. Company in process of identifying successor. No succession timeline or interim arrangements disclosed.
Chinese players maintaining irrational pricing across core specialty chemical products, forcing SRF to protect market share over margins. Sequential margin contraction of 170-180bps observed. Timing of Chinese correction remains unpredictable.
R32 falls under US tariffs unlike R134a, causing customers to shift from annual contracts to month-to-month purchasing. Increased transaction costs and business reallocation from India to Thailand plant to avoid tariffs, raising logistics costs.
BOP/BOPET volumes impacted by GST 2.0 repackaging requirements and cheap Chinese imports. Technical textiles facing sustained pressure on belting fabrics due to aggressive Chinese pricing and reduced conveyor belt exports to US. Margins unlikely to improve near-term.
Demand deferment for key agro products continues despite management expressing confidence in revival signs. Analyst pressed on lead indicators for cycle turn; management cited global commodity prices normalization (soya) as key signal. One AI launch tracking for FY26 per earlier guidance.
Sales into the Middle East were impacted in Q4 due to geopolitical tensions, though management rerouted shipments to other markets.
Sharp rupee depreciation led to mark-to-market losses on forward hedges, impacting FY26 results and expected to persist near-term.
Aggressive Chinese pricing has compressed margins in specialty chemicals; management expects normalization but timing uncertain.
Government has not clarified whether HCFC production will be included in baseline quota calculations, creating regulatory risk for HFC capacity expansion.